Various local hemostatic agents with different modes of action;: an in vivo comparative randomized vascular surgical experimental study

被引:44
作者
Bjorses, K. [1 ]
Holst, J. [1 ]
机构
[1] Lund Univ, Malmo Univ Hosp, Dept Vasc Dis, S-20502 Malmo, Sweden
关键词
local hemostasis; bovine thrombin; microporous polysaccharide hemispheres; recombinant FVIIa;
D O I
10.1016/j.ejvs.2006.10.011
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objectives. To evaluate the effects of different local hemostatic agents in a new high flow vascular experimental bleeding model. Design. Bovine thrombin combined with collagen matrix (bTcM), microporous polysaccharide hemospheres (MPH), freeze-dried rFVIIa with and without the combination of MPH were compared to a control group (solely compression) in a randomized fashion (20 animals/group). Primary endpoint was hemostasis, and secondary endpoints were time to hemostasis, blood loss, and blood pressure at hemostasis. Methods. The common carotid artery of heparinized rats was ligated proximally and transected. Compression was applied for one minute followed by application of the topical hemostatic agent. Compression was maintained for another two minutes followed by re-evaluation of hemostasis: if bleeding continued additional compression was applied and thereafter bleeding was checked every minute until hemostasis. Results. All animals in the bTcM group obtained hemostasis compared to 20% in the control. group (p < 0.0001). The combination of MPH and rFVIIa (70% hemostasis) also showed a significant hemostatic capacity compared to control group (p < 0.001). None of the other active treatment groups differed compared to control group. Animals treated with bTcM had a significantly shorter time to hemostasis compared to animals in the other active treatment groups. No significant difference in blood loss and blood pressure at hemostasis was detected. Conclusions. The most effective hemostatic agent was bTcM, followed by the combination of rFVIIa and MPH, while neither MPH nor rFVIIa alone displayed any hemostatic capacity compared to compression only.
引用
收藏
页码:363 / 370
页数:8
相关论文
共 24 条
[1]   Comparative analysis of hemostatic agents in a swine model of lethal groin injury [J].
Alam, HB ;
Uy, GB ;
Miller, D ;
Koustova, E ;
Hancock, T ;
Inocencio, R ;
Anderson, D ;
Llorente, O ;
Rhee, P .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2003, 54 (06) :1077-1082
[2]   Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: Two parallel randomized, placebo-controlled, double-blind clinical trials [J].
Boffard, KD ;
Riou, B ;
Warren, B ;
Choong, PIT ;
Rizoli, S ;
Rossaint, R ;
Axelsen, M ;
Kluger, Y .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2005, 59 (01) :8-16
[3]   A polymeric sealant inhibits anastomotic suture hole bleeding more rapidly than gelfoam/thrombin - Results of a randomized controlled trial [J].
Glickman, M ;
Gheissari, A ;
Money, S ;
Martin, J ;
Ballard, JL .
ARCHIVES OF SURGERY, 2002, 137 (03) :326-331
[4]   Potential role for rFVIIa in transfusion medicine [J].
Hedner, U ;
Erhardtsen, E .
TRANSFUSION, 2002, 42 (01) :114-124
[5]   Use of recombinant activated factor VII to treat the acquired coagulopathy of trauma [J].
Holcomb, JB .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2005, 58 (06) :1298-1303
[6]   Hemostatic efficacy of a fibrin sealant dressing in an animal model of kidney injury [J].
Jackson, MR ;
Taher, MM ;
Burge, JR ;
Krishnamurti, C ;
Reid, TJ ;
Alving, BM .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1998, 45 (04) :662-665
[7]   Fibrin sealant: Current and potential clinical applications [J].
Jackson, MR ;
MacPhee, MJ ;
Drohan, WN ;
Alving, BM .
BLOOD COAGULATION & FIBRINOLYSIS, 1996, 7 (08) :737-746
[8]   Comparative study of the efficacy of the common topical hemostatic agents with fibrin sealant in a rabbit aortic anastomosis model [J].
Kheirabadi, BS ;
Field-Ridley, A ;
Pearson, R ;
MacPhee, M ;
Drohan, W ;
Tuthill, D .
JOURNAL OF SURGICAL RESEARCH, 2002, 106 (01) :99-107
[9]   Low-molecular-weight heparin (dalteparin) effectively prevents thrombosis in a rat model of deep arterial injury [J].
Malm, K ;
Dahlbäck, B ;
Arnljots, B .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2003, 111 (05) :1659-1666
[10]   Recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery [J].
Manning, BJ ;
Hynes, N ;
Courtney, DF ;
Sultan, S .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2005, 30 (05) :525-527